Mulcare R J, Royster T S, Weiss H J, Phillips L L
Ann Surg. 1974 Sep;180(3):343-9. doi: 10.1097/00000658-197409000-00015.
A retrospective review was done of all patients undergoing surgical repair of abdominal aortic aneurysm (AAA) on whom coagulation studies were obtained. Those patients with laboratory documented disseminated intravascular coagulation (DIC) were selected and their clinical records reviewed. This included 7 patients studied in the periods 1964-1965 and January 1971-July 1973. Of these 7 cases, 4 occurred in patients undergoing emergency operation for ruptured aneurysm and 3 were in elective cases. All 7 patients exhibited clinical evidence of abnormal bleeding, while 6 of the 7 progressed rapidly to renal shutdown. The seventh patient recovered spontaneously. Of the 6 patients with full blown clinical and laboratory evidence of DIC, 2 recovered. Both cases received heparin therapy and multiple hemodialyses. A third patient was started on heparin but died at 36 hours in heart failure. All 3 patients receiving heparin showed clinical cessation of abnormal bleeding and disappearance of soluble fibrin monomer complexes within 24 hours of starting therapy. The study suggests a higher incidence of DIC than has previously been appreciated in both the emergency and elective repair of AAA. The prompt recognition and treatment of this complication may reverse the abnormal intravascular clotting, minimize its more serious results and avoid futile and dangerous operative intervention.
对所有接受腹主动脉瘤(AAA)手术修复且进行了凝血研究的患者进行了回顾性研究。选择那些实验室记录有弥散性血管内凝血(DIC)的患者,并对其临床记录进行回顾。这包括1964 - 1965年以及1971年1月至1973年7月期间研究的7例患者。在这7例病例中,4例发生在因动脉瘤破裂接受急诊手术的患者中,3例为择期手术病例。所有7例患者均有异常出血的临床证据,而7例中有6例迅速发展为肾衰竭。第7例患者自发康复。在6例有充分临床和实验室证据表明患有DIC的患者中,2例康复。这两例患者均接受了肝素治疗和多次血液透析。第3例患者开始接受肝素治疗,但在36小时时死于心力衰竭。所有3例接受肝素治疗的患者在开始治疗后24小时内临床异常出血停止,可溶性纤维蛋白单体复合物消失。该研究表明,在AAA的急诊和择期修复中,DIC的发生率比以前认识到的要高。对这种并发症的及时识别和治疗可能会逆转异常的血管内凝血,将其更严重的后果降至最低,并避免徒劳和危险的手术干预。